These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18577969)

  • 1. [The role of lipid peroxidation in gall bladder stone formation].
    Galimov OV; Fakhrutdinov RR; Khanov VO; Ronzhin AE; Bykova VM
    Khirurgiia (Mosk); 2008; (5):37-9. PubMed ID: 18577969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Galvanization of the liver in the prevention of cholelithiasis in patients with chronic cholecystitis].
    Antipenko PV; Ponomarenko GN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (1):20-1. PubMed ID: 9190749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of hyperlipoperoxidation in the development of chronic acalculous and calculous cholecystitis].
    Tadzhiev IIa
    Klin Med (Mosk); 1991 Jul; 69(7):70-4. PubMed ID: 1942984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation of the bile in patients with calculous and acalculous cholecystitis].
    Shvetsova MM; Barbot'ko AA; Luk'ianchikov GF; Lun'kov VD
    Patol Fiziol Eksp Ter; 1998; (4):33-5. PubMed ID: 9951302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lithogenicity of bile and serum lipoproteins (A) in cholelitiasis in women].
    Grigor'eva IN; Nikitenko TM; Tikhonov AV
    Eksp Klin Gastroenterol; 2009; (3):4-8. PubMed ID: 19938284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystitis, gallstones and free radical reactions in human gallbladder.
    Sipos P; Krisztina H; Blázovics A; Fehér J
    Med Sci Monit; 2001; 7(1):84-8. PubMed ID: 11208499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients.
    Jüngst C; Sreejayan N; Eder MI; von Stillfried N; Zündt B; Spelsberg FW; Kullak-Ublick GA; Jüngst D; von Ritter C
    Eur J Clin Invest; 2007 Sep; 37(9):731-6. PubMed ID: 17696963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseases.
    Petrikkos G; Kastanakis M; Markogiannakis A; Kastanakis S; Bastounis E; Antonios P; Daikos GL; Katsilambros N
    Int J Antimicrob Agents; 2006 Apr; 27(4):331-4. PubMed ID: 16563705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical indices of the bile in cholecystitis patients].
    Valenkevich LN
    Vrach Delo; 1987 Jul; (7):60-2. PubMed ID: 3630124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Correlations of the indicators of biochemical composition and physico-chemical properties of the bile in chronic cholecystitis].
    Tadziev IIa; Tsodikov GV
    Klin Med (Mosk); 1989 Nov; 67(11):52-8. PubMed ID: 2625961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peculiarities of lipid metabolism in pregnant patients with chronic cholecystitis].
    Merabishvili N; Kamladze S; Sulaberidze G
    Georgian Med News; 2006 Dec; (141):14-7. PubMed ID: 17261878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Crystallo-optic structures of bile in chronic acalculous cholecystitis].
    Savina LV; Kokueva OV; Golovanova ES; Kadygrob GV
    Eksp Klin Gastroenterol; 2002; (5):59-62, 128. PubMed ID: 12619579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of drug biotransformation reactions and cellular viability in the livers of patients with biliary diseases.
    Hietanen E; Auranen A; Savvakis Ch
    Acta Hepatogastroenterol (Stuttg); 1975 Jun; 22(3):170-5. PubMed ID: 1220509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bile composition in patients with chronic cholecystitis].
    Marksiti LT
    Vrach Delo; 1976 Dec; (12):80-2. PubMed ID: 1014597
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of health resort treatment on the bile levels of free amino acids in chronic cholecystitis].
    Manto IE; Liubetskiĭ AS
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (4):36-8. PubMed ID: 6636606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of biliary stasis on lipid peroxidation and bile composition in in vitro experiment].
    Shvetsova MM; Barbot'ko AA; Luk'ianchikov GF; Okhotnikov OI; Lun'kov VD
    Biull Eksp Biol Med; 1998 Feb; 125(2):200-3. PubMed ID: 9559138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemistry and bile lithogenic properties in biliary pathology].
    Tsimmerman IaS; Bondar' OD; Shchekotova AP
    Klin Med (Mosk); 1981 Apr; 59(4):48-51. PubMed ID: 7241991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Galstena efficacy in patients with biliary dyskinesia, chronic cholecystitis and cholelithiasis].
    Grigor'eva IN; Shabalin AV; Tikhonov AV; Moiseenko EE; Ragino IuI
    Klin Med (Mosk); 2001; 79(11):52-4. PubMed ID: 11811112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithogenesis and bile metabolism.
    Lambou-Gianoukos S; Heller SJ
    Surg Clin North Am; 2008 Dec; 88(6):1175-94, vii. PubMed ID: 18992590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.